PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an ...

Tonix Pharmaceuticals has licensed oxytocin-based therapeutic technology for the treatment of rare genetic disorder Prader-Willi syndrome. The agreement with French research institute Inserm continues ...

Please provide your email address to receive an email when new articles are posted on . Almirall S.A. and Inserm Transfert have entered an agreement to advance research in vitiligo treatment, the two ...

Heart failure affects over one million people in France. Although the blood system is the first to have been explored for the purpose of improving heart function, a study by Inserm has revealed the ...

BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health. Inserm made the ...

Patrice Cani (UCLouvain) and Claude Knauf (INSERM) have discovered a "jammer" that blocks communication between the gut and the brain, thus preventing proper regulation of sugar and causing insulin ...

Global artificial intelligence (AI) company, Expert System has announced that the French National Institute of Health and Medical Research, Inserm, will implement its Clinical Research Navigator (CRN) ...

Dassault Systèmes has entered into a clinical trial technology pact with French public health research institute Inserm. The alliance will see Dassault provide its 3DEXPERIENCE platform to Inserm ...

OSE Immunotherapeutics SA, a biotech company dedicated to developing first-in-class assets in immuno-oncology and immuno-inflammation, Inserm Transfert (on behalf of Inserm, a French public ...

French researchers are rebelling against a decision to include foreign experts in policy decisions at the country's National Institute of Health and Medical Research (INSERM). Beginning 21 June, eight ...